MICS and TSV Combined

Article

Doube optimization for improved solutions

There are several reasons in support of combining anterior and posterior segment surgery. For instance, eyes presenting for cataract surgery may also have vitreoretinal problems, from vitreous degeneration to epiretinal membrane and macular hole, from diabetic retinopathy to retinal vein occlusion requiring laser treatment, and up to retinal detachment.

Recent research found epiretinal membrane in 7% of eyes presenting for cataract surgery.1 However, eyes with retinal problems can also develop cataract, both during surgery in the case of lens touch, or after surgery especially in the case of posterior tamponade by silicone oil.

The removal of a cataract in the absence of vitreous faces zonular weakness, anterior chamber instability, zonula relaxation, and the possible development of plaques especially on the posterior capsulae. In contrast, simultaneous cataract removal and posterior vitrectomy allows the surgeon to complete the vitrectomy with full shaving of the vitreous base, and to obtain better posterior tamponade with less chance of PVR recurrence. In addition, both the patient and the surgeon benefit from the single procedure for cost reason, and for the single infection risk.

MICS just before posterior surgery

The modern approach to combined anterior and posterior segment surgery includes microincision cataract surgery (MICS) and transconjunctival sutureless vitrectomy (TSV). New machines are being developed, specifically designed to optimize both types of surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.